NBNeus Badosa

Neus Badosa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Neus Badosa has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effectiveness of a nurse-led telemedicine-based program for pharmacological and prognostic optimization of patients with heart failure and reduced ejection fraction: the MAR-HF-Titration study

    by Sonia Ruiz-Bustillo, Miren Vicente, Pilar Ruiz-Rodriguez, Ana María Linás-Alonso, Sandra Valdivielso-Moré, Núria Farré, Laia Belarte-Tornero, Ronald Morales-Murillo, Joan Vime-Jubany, Neus Badosa, et al.

    Aims: Guidelines emphasize the importance of quadruple therapy in heart failure with reduced ejection fraction (HFrEF), and of achieving target doses quickly. The aim of the MAR-HF-Titration study was to assess the effectiveness of a nurse-led, telemedicine programme for this purpose. Methods and results: Prospective study including 210 HFrEF patients between September 2021 and December 2023. The 6-month follow-up used a telemedicine programme involving daily telemonitoring of vital signs, weight and symptoms, routine laboratory test monitoring, videoconferences and the use of algorithms for drug titration. Mean age was 70 years, 35% women. Mean left ventricle ejection fraction (LVEF) was 31%, 60% had a non-ischaemic aetiology, and 61% newly diagnosed HF. After the intervention, significant increases were achieved in the use of quadruple therapy at any dose (63 vs. 75%; P = 0.001), at ≥50% of the target doses of each drug (10 vs. 44%, P < 0.001), and at target doses of all drugs (0 vs. 19%, P < 0.001). Median titration time was 45 days for beta-blockers, 65 for MRA, and 69 for ARNI. Older age, chronic kidney disease, hypotension, and higher NTproBNP were associated with lower odds of effective titration. The LVEF increased (31–45%, P < 0.001) and the NTproBNP values were significantly reduced (1960–806 pg/mL, P < 0.001). Increases in the use of prognostic medications were also observed in a sub-analysis restricted to participants aged ≥75 years. Conclusion: Our intensive, nurse-led, telemedicine-based programme attained a fast optimization of prognostic therapies in HFrEF and resulted in significant improvements in parameters with prognostic relevance.


  • Empowerment trajectories in patients with chronic heart failure: a descriptive correlational study

    by Paloma Garcimartín, Guillermo Pedreira-Robles, Neus Badosa, Anna Linas, Laia Rosenfeld, Mercedes Faraudo, Esther Calero, Elena Calvo, Nuria Jose, Josep Comín-Colet

    Aims: Patient empowerment is a key factor in the management of chronic heart failure (HF), as it enables individuals to better understand and manage their condition, improve outcomes, and reduce the risk of decompensation. This study aims to identify predictors of baseline empowerment and its changes (improvement or deterioration) in patients with HF. Examining empowerment trajectories can help identify patients at risk of deterioration and support the design of tailored interventions. Methods and Results: Sociodemographic, clinical, psychosocial, HRQoL, self-care, and empowerment questionnaire data were collected at baseline and at 12 weeks. Empowerment evolution was calculated as the difference between baseline and 12-week empowerment values, categorized as improvement, no change, or deterioration. The sample was analyzed descriptively, and bivariate, linear, and regression models were applied. Factors associated with lower baseline empowerment included functional class (p=0.01) and anxiety (p=0.01). Predictors of empowerment deterioration were age (p=0.003), functional class (p=0.037), and dependency level (p=0.047). Regression analyses showed that advanced age (p<0.03), cognitive status (p=0.006), and level of dependency (p=0.002) were the main determinants of deterioration in empowerment over time. Conclusion: Poor functional status and anxiety were associated with lower baseline empowerment levels. Advanced age, cognitive decline, and higher dependency were significant predictors of worsening empowerment over time. These findings emphasize the need for tailored interventions to address functional, psychological, and cognitive challenges in patients with HF to support their empowerment and improve health outcomes.


  • Open Access

    Quality of Life in Older Patients after a Heart Failure Hospitalization: Results from the SENECOR Study

    by Daniele Luiso, Marta Herrero-Torrus, Neus Badosa, Cristina Roqueta, Sonia Ruiz-Bustillo, Laia C. Belarte-Tornero, Sandra Valdivielso-Moré, Ronald O. Morales, Olga Vázquez, Núria Farré

    Background: Information about health-related quality of life (HRQoL) in heart failure (HF) in older adults is scarce. Methods: We aimed to describe the HRQoL of the SENECOR study cohort, a single-center, randomized trial comparing the effects of multidisciplinary intervention by a geriatrician and a cardiologist (intervention group) to that of a cardiologist alone (control group) in older patients with a recent HF hospitalization. Results: HRQoL was assessed by the short version of the disease-specific Kansas Cardiomyopathy Questionnaire (KCCQ-12) in 141 patients at baseline and was impaired (KCCQ-12 < 75) in almost half of the cohort. Women comprised 50% of the population, the mean age was 82.2 years, and two-thirds of patients had preserved ejection fraction. Comorbidities were highly prevalent. Patients with impaired HRQoL had a worse NYHA functional class, a lower NT-proBNP, a lower Barthel index, and a higher Clinical Frailty Scale. One-year all-cause mortality was 22.7%, significantly lower in the group with good-to-excellent HRQoL (14.5% vs. 30.6%; hazard ratio 0.28; 95% confidence interval 0.10–0.78; p = 0.014). In the group with better HRQoL, all-cause hospitalization was lower, and there was a trend towards lower HF hospitalization. Conclusions: The KCCQ-12 questionnaire can provide inexpensive prognostic information even in older patients with HF. (Funded by grant Primitivo de la Vega, Fundación MAPFRE. ClinicalTrials number, NCT03555318).


  • Open Access

    Randomized Controlled Trial Comparing a Multidisciplinary Intervention by a Geriatrician and a Cardiologist to Usual Care after a Heart Failure Hospitalization in Older Patients: The SENECOR Study

    by Marta Herrero-Torrus, Neus Badosa, Cristina Roqueta, Sonia Ruiz-Bustillo, Eduard Solé-González, Laia C. Belarte-Tornero, Sandra Valdivielso-Moré, Olga Vázquez, Núria Farré

    Background: The prognosis of older patients after a heart failure (HF) hospitalization is poor. Methods: In this randomized trial, we consecutively assigned 150 patients 75 years old or older with a recent heart failure hospitalization to follow-up by a cardiologist (control) or follow-up by a cardiologist and a geriatrician (intervention). The primary outcome was all-cause hospitalization at a one-year follow-up. Results: All-cause hospitalization occurred in 47 of 75 patients (62.7%) in the intervention group and in 58 of 75 patients (77.3%) in the control group (hazard ratio, 0.67; 95% confidence interval, 0.46 to 0.99; p = 0.046). The number of patients with at least one HF hospitalization was similar in both groups (34.7% in the intervention group vs. 40% in the control group, p = 0.5). There were a total of 236 hospitalizations during the study period. The main reasons for hospitalization were heart failure (38.1%) and infection (14.8%). Mortality was 24.7%. Heart failure was the leading cause of mortality (54.1% of all deaths), without differences between groups. Conclusions: A follow-up by a cardiologist and geriatrician in older patients after an HF hospitalization was superior to a cardiologist’s follow-up in reducing all-cause hospitalization in older patients. (Funded by Beca Primitivo de la Vega, Fundación MAPFRE. ClinicalTrials.gov number, NCT03555318).


  • Open Access

    Prognostic Utility of a New Risk Stratification Protocol for Secondary Prevention in Patients Attending Cardiac Rehabilitation

    by Ignacio Cabrera-Aguilera, Consolació Ivern, Neus Badosa, Ester Marco, Xavier Duran, Diana Mojón, Miren Vicente, Marc Llagostera, Nuria Farré, Sonia Ruíz-Bustillo

    Several risk scores have been used to predict risk after an acute coronary syndrome (ACS), but none of these risk scores include functional class. The aim was to assess the predictive value of risk stratification (RS), including functional class, and how cardiac rehabilitation (CR) changed RS. Two hundred and thirty-eight patients with ACS from an ambispective observational registry were stratified as low (L) and no-low (NL) risk and classified according to exercise compliance; low risk and exercise (L-E), low risk and control (no exercise) (L-C), no-low risk and exercise (NL-E), and no-low risk and control (NL-C). The primary endpoint was cardiac rehospitalization. Multivariable analysis was performed to identify variables independently associated with the primary endpoint. The L group included 56.7% of patients. The primary endpoint was higher in the NL group (18.4% vs. 4.4%, p < 0.001). After adjustment for age, sex, diabetes, and exercise in multivariable analysis, HR (95% CI) was 3.83 (1.51–9.68) for cardiac rehospitalization. For RS and exercise, the prognosis varied: the L-E group had a cardiac rehospitalization rate of 2.5% compared to 26.1% in the NL-C group (p < 0.001). Completing exercise training was associated with reclassification to low-risk, associated with a better outcome. This easy-to-calculate risk score offers robust prognostic information. No-exercise groups were independently associated with the worst outcomes. Exercise-based CR program changed RS, improving classification and prognosis.